EGTA
Molecular Structure:
MDL:
--MFCD00004291
Molecular Formula:
C14H24N2O10;[-CH2OCH2CH2N(CH2CO2H)2]2
Molecular Weight:
380.35
Alias:
乙二醇双(2-氨基乙醚)四醋酸,乙二醇二乙醚二胺四乙酸,乙二醇双α-氨基乙基醚四乙酸,乙二醇-双-2-氨基乙基四乙酸,乙二醇双(2-氨基乙基)四乙酸Ethylene glycol-bis-(2-aminoethylether)-N,N,N′,N′-tetraacetic acid
Chel™-DE
Egtazic acid
Ethylene-bis(oxyethylenenitrilo)tetraacetic acid
Glycol ether diamine tetraacetic acid
1,2-Bis[2-[bis(carboxymethyl)amino]ethoxy]ethane
EGTA
Ethylene Glycol Bis(2-aminoethylether)-N,N,N',N'-tetraacetic
Product order:
Name |
Specifications |
Packing |
Price |
Delivery |
EGTA |
用于分子生物学, ≥99.0% |
5g |
RMB 165 |
现货 |
EGTA |
用于分子生物学, ≥99.0% |
10g |
RMB 264 |
现货 |
EGTA |
AR |
500g |
RMB 1210 |
Consulting service |
EGTA |
AR |
100g |
RMB 308 |
Consulting service |
Character:
白色结晶性粉末。溶于碱溶液,几乎不溶于水。
熔点:241℃
Quality Standard:
项目 分析纯
(AR)
含量Assay ≥99.0%
氯化物(Cl)Chloride ≤0.005%
络合力试验complexing 合格
氢氧化钠溶解试验Solubility in NaOH 合格
铁Iron(Fe) ≤0.001%
重金属Heavy Metals ≤0.001%
灼烧残渣Ignition residue ≤0.05%
Storage:
密封保存。
用途 EGTA是最为被广泛使用的钙离子选择性的螯合剂。它与钙离子形成的复合物比与镁离子形成的复合物要稳定100,000倍,被用来制备钙缓冲液和控制钙离子的浓度。容量分析及光度分析中测量微量金属的络合剂、掩蔽剂。也可滴定钡、锶、铜、镁和锌。
Related Products
- DL-Lactic acid
- 3-Methoxy-2-methylbenzoic acid
- 10-Undecenoic acid
- 5-Bromosalicylic acid
- (S)-(−)-2-Chloropropanoic acid
- 4-(Dimethylamino)cinnamic acid
- Decanoic acid
- Retinoic acid
- Ethephon
- Behenic acid
- DL-4-Hydroxy-3-methoxymandelic acid
- Quinoline-5-carboxylic
- Iminodiacetic acid
- 4-Bromophenylacetic Acid
- Palmitoleic acid
- Lipoic acid
- 4-Chlorophenoxyacetic acid
- 1H-indole-7-carboxylic acid
- 5,5'-Dithio bis-(2-nitrobenzoic acid)
- (R)-(−)-2-Chloromandelic acid
- Protocatechuic acid
- 4-(Trifluoromethoxy)benzoic acid
- Isotretinoin
- S-(Thiobenzoyl)thioglycolic acid
- Levofloxacin carboxylic acid
- 3-Nitrobenzoic acid
- 5-Methylisoxazole-3-carboxylic acid
- 4-Bromo-2-methylbenzoic Acid
- trans-2-Nitrocinnamic acid
- p-Toluic acid
- Lithocholic acid
- 9-Anthroic acid
- Bromosuccinic acid
- 2,2-Bis(hydroxymethyl)butyric acid
- 3-Phenylglutaric acid
- Salicylic acid
- EGTA
- 3-(Trifluoromethyl)cinnamic acid, predominantly trans
- trans-2,3,4-Trimethoxycinnamic
- 4-Amino-3-hydroxybenzoic acid
- 2,6-Dichlorocinnamic acid, predominantly trans
- 3-Methylvaleric acid
- α-Oxo-2-furanacetic acid
- 3-Methoxycinnamic acid
- L-2-Aminobutyric acid
- Xanthurenic acid
- 1-Octyl-2-pyrrolidone
- Hydrocortisone 21-acetate
- Undecafluorohexanoic acid
- Acetic acid-d4
- trans-1,4-Cyclohexanedicarboxylic acid
- 4-Phenoxybenzoic Acid
- Sulfuric acid-d2 solution
- 2-Aminobenzenesulfonic Acid
- 1-Acetylpiperidine-4-carboxylic acid
- cis-Aconitic acid
- 3,6,9-Trioxaundecanedioic acid
- 3-Phosphonopropionic acid
- 2-Thiopheneacetic acid
- 4-Hydroxyphenylacetic acid
- 3,4-Difluorophenylacetic acid
- 1-Naphthylboronic acid
- Phloretic acid
- 3-(Trifluoromethyl)phenylboronic acid
- Silicotungstic acid
- 2-Amino-5-bromonicotinic acid
- (1-Aminobutyl)phosphonic acid
- 4-Iodobenzoic acid
- 4-AMINO-5-CHLORO-2-METHOXYBENZOIC ACID
- Tricosanoic acid
- Poly(acrylic acid)
- Ginkgolic acid C15:1
- Poly(acrylic acid)
- Poly(3,4-ethylenedioxythiophene)-poly(styrenesulfonate)
- Erucic acid
- 3-Aminopyrazole-4-carboxylic acid
- 4-Hydroxybenzenesulfonic acid
- 6-AMINO-2-NAPHTHOIC ACID
- 5-Bromo-2-iodobenzoic acid
- 3-Mercaptobenzoic acid